237 related articles for article (PubMed ID: 37763334)
1. Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
Churov AV; Chegodaev YS; Khotina VA; Ofitserov VP; Orekhov AN
Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763334
[TBL] [Abstract][Full Text] [Related]
2. Depletion of Foxp3
Kasahara K; Sasaki N; Amin HZ; Tanaka T; Horibe S; Yamashita T; Hirata KI; Rikitake Y
Heliyon; 2022 Jul; 8(7):e09981. PubMed ID: 35898604
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells as a new therapeutic target for atherosclerosis.
Ou HX; Guo BB; Liu Q; Li YK; Yang Z; Feng WJ; Mo ZC
Acta Pharmacol Sin; 2018 Aug; 39(8):1249-1258. PubMed ID: 29323337
[TBL] [Abstract][Full Text] [Related]
4. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells.
Dietel B; Cicha I; Voskens CJ; Verhoeven E; Achenbach S; Garlichs CD
Atherosclerosis; 2013 Sep; 230(1):92-9. PubMed ID: 23958259
[TBL] [Abstract][Full Text] [Related]
5. Latency-associated peptide (LAP)
Yu J; Xu W; Dong Q; Ji Q; Cheng M; Hu D; Cai Y; Zeng Q; Yu K
Clin Immunol; 2023 Oct; 255():109767. PubMed ID: 37689092
[TBL] [Abstract][Full Text] [Related]
6. KLF10 deficiency in CD4
Wara AK; Rawal S; Yang X; Pérez-Cremades D; Sachan M; Chen J; Feinberg MW
Atherosclerosis; 2022 Oct; 359():27-41. PubMed ID: 36174463
[TBL] [Abstract][Full Text] [Related]
7. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T Cell Immunity in Atherosclerosis.
Amin HZ; Sasaki N; Hirata KI
Acta Med Indones; 2017 Jan; 49(1):63-68. PubMed ID: 28450656
[TBL] [Abstract][Full Text] [Related]
9. Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets.
Xia Y; Gao D; Wang X; Liu B; Shan X; Sun Y; Ma D
Front Immunol; 2024; 15():1331609. PubMed ID: 38558816
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B
Wolf D; Gerhardt T; Winkels H; Michel NA; Pramod AB; Ghosheh Y; Brunel S; Buscher K; Miller J; McArdle S; Baas L; Kobiyama K; Vassallo M; Ehinger E; Dileepan T; Ali A; Schell M; Mikulski Z; Sidler D; Kimura T; Sheng X; Horstmann H; Hansen S; Mitre LS; Stachon P; Hilgendorf I; Gaddis DE; Hedrick C; Benedict CA; Peters B; Zirlik A; Sette A; Ley K
Circulation; 2020 Sep; 142(13):1279-1293. PubMed ID: 32703007
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T-cells, FoxP3 and atherosclerosis.
Entin-Meer M; Afek A; George J
Adv Exp Med Biol; 2009; 665():106-14. PubMed ID: 20429419
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances on the Role and Therapeutic Potential of Regulatory T Cells in Atherosclerosis.
Tanaka T; Sasaki N; Rikitake Y
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945203
[TBL] [Abstract][Full Text] [Related]
13. T cell subsets and functions in atherosclerosis.
Saigusa R; Winkels H; Ley K
Nat Rev Cardiol; 2020 Jul; 17(7):387-401. PubMed ID: 32203286
[TBL] [Abstract][Full Text] [Related]
14. The alternation of autophagy/apoptosis in CD4+CD25+Foxp3+ Tregs on the developmental stages of atherosclerosis.
Tian Y; Liang X; Wu Y
Biomed Pharmacother; 2018 Jan; 97():1053-1060. PubMed ID: 29136784
[TBL] [Abstract][Full Text] [Related]
15. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions.
de Boer OJ; van der Meer JJ; Teeling P; van der Loos CM; van der Wal AC
PLoS One; 2007 Aug; 2(8):e779. PubMed ID: 17712427
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.
Foks AC; Frodermann V; ter Borg M; Habets KL; Bot I; Zhao Y; van Eck M; van Berkel TJ; Kuiper J; van Puijvelde GH
Atherosclerosis; 2011 Sep; 218(1):53-60. PubMed ID: 21621777
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFNγ+ Th1/Tregs.
Butcher MJ; Filipowicz AR; Waseem TC; McGary CM; Crow KJ; Magilnick N; Boldin M; Lundberg PS; Galkina EV
Circ Res; 2016 Nov; 119(11):1190-1203. PubMed ID: 27635087
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4
Wang F; Liu M; Ma D; Cai Z; Liu L; Wang J; Zhang W; Zhao L; Zhai C; Xu Y
Int Immunopharmacol; 2023 Mar; 116():109758. PubMed ID: 36706593
[TBL] [Abstract][Full Text] [Related]
19. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
[TBL] [Abstract][Full Text] [Related]
20. Treating atherosclerosis with regulatory T cells.
Foks AC; Lichtman AH; Kuiper J
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
